Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 111,189 | reported | 05 May 2026 | tx 20+239,621−18,814 |
| ABEONA THERAPEUTICS INC. | 37,313 | reported | 15 May 2026 | tx 6+84,458−47,145 |
| Dimension Therapeutics, Inc. | 0 | reported | 07 Nov 2017 | tx 6+100,000−308,688 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 May 2026 | SALE | ABEONA THERAPEUTICS INC. | 26,143 | 5.53 USD | 10b5-1 |
| 05 May 2026 | SALE | Ultragenyx Pharmaceutical Inc. | 344 | 24.96 USD | |
| 16 Apr 2026 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 34,674 | 0.00 USD | |
| 16 Apr 2026 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 59,952 | 0.00 USD | deriv |
| 01 Mar 2026 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 11,643 | 0.00 USD | |
| 02 Mar 2026 | SALE | Ultragenyx Pharmaceutical Inc. | 7,029 | 22.80 USD | |
| 02 Feb 2026 | SALE | ABEONA THERAPEUTICS INC. | 16,284 | 5.09 USD | |
| 26 Jan 2026 | GRANT_AWARD | ABEONA THERAPEUTICS INC. | 37,313 | 0.00 USD | |
| 14 Aug 2025 | SALE | ABEONA THERAPEUTICS INC. | 4,718 | 6.93 USD | |
| 05 May 2025 | SALE | Ultragenyx Pharmaceutical Inc. | 520 | 39.24 USD | |
| 21 Apr 2025 | SALE | Ultragenyx Pharmaceutical Inc. | 242 | 35.11 USD | |
| 01 Mar 2025 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 14,971 | 0.00 USD | |
| 01 Mar 2025 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 16,813 | 0.00 USD | |
| 03 Mar 2025 | SALE | Ultragenyx Pharmaceutical Inc. | 8,945 | 42.10 USD | |
| 01 Mar 2025 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 30,246 | 0.00 USD | deriv |
| 31 Jan 2025 | GRANT_AWARD | ABEONA THERAPEUTICS INC. | 36,101 | 0.00 USD | |
| 13 Aug 2024 | GRANT_AWARD | ABEONA THERAPEUTICS INC. | 11,044 | 0.00 USD | |
| 02 May 2024 | SALE | Ultragenyx Pharmaceutical Inc. | 354 | 43.66 USD | |
| 18 Apr 2024 | SALE | Ultragenyx Pharmaceutical Inc. | 142 | 44.10 USD | |
| 01 Mar 2024 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 19,400 | 0.00 USD | |
| 01 Mar 2024 | SALE | Ultragenyx Pharmaceutical Inc. | 1,238 | 53.76 USD | |
| 01 Mar 2024 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 34,200 | 0.00 USD | deriv |
| 01 Mar 2024 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 2,351 | 0.00 USD | deriv |
| 27 Sept 2023 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 2,351 | 0.00 USD | deriv |
| 01 May 2023 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 4,658 | 0.00 USD |